Gobalan Krishnasamy

Evaluation of Potential EGFR Inhibitors for Non-small Cell Lung Cancer: A Structure-based Virtual Screening and Molecular Dynamics Study

Gobalan Krishnasamy, Sudharsan Parthasarathy, Shalini Rajasekaran, T. William Raja, S. Geet Andrea & Siva Vijayakumar Tharumasivam · Journal of Pharmaceutical Research International · 2024

Non-small cell lung cancer is a leading cause of cancer deaths globally. EGFR is one of the attractive drug targets for non small cell lung cancer. It was first identified receptor tyrosine kinase receptor. It plays a critical role in the variety of biological activity apoptosis,...